Afficher la couverture 'Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial | Carson, Jeffrey' en grand format
/5

0 avis

Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

Archive ouverte

Carson, Jeffrey | Brooks, Maria Mori | Chaitman, Bernard | Alexander, John | Goodman, Shaun | Bertolet, Marnie | Abbott, J. Dawn | Cooper, Howard | Rao, Sunil | Triulzi, Darrell | Fergusson, Dean | Kostis, William | Noveck, Helaine | Simon, Tabassome | Steg, Philippe Gabriel | Defilippis, Andrew | Goldsweig, Andrew | Lopes, Renato | White, Harvey | Alsweiler, Caroline | Morton, Erin | Hébert, Paul | Ghafghazi, Shahab | Wood, Frances | Menegus, Mark | Uretsky, Barry | Vallurupalli, Srikanth | Maniatis, Gregory | Gruberg, Luis | Roswell, Robert | Rossi, Joseph | Abtahian, Farhad | Tessalee, Meechai | Barsness, Gregory | Aronow, Herbert | Ramanathan, Kodangudi | Schmidhofer, Mark | Keating, Friederike | Carson, Michael | Kontos, Michael | Qureshi, Mansoor | Clegg, Stacey | Laskey, Warren | Polonsky, Tamar | Gupta, Rajesh | Sheikh, Mujeeb Abdul | Uhl, Lynne | Mullen, Paul | Bracey, Arthur | Matthai, William | Stowell, Christopher | Dudzinski, David | Marhefka, Gregary | Weinstock, Perry | Lawson, William | Keller, Norma | Yuriditsky, Eugene | Thomas, Michael | Jacobs, Alice | Hochberg, Claudia | Siddiqi, Omar | Schulman-Marcus, Joshua | Torosoff, Mikhail | Gitter, Michael | Dai, Xuming | Traverse, Jay | Mccamant, Eric | Scott, Jason | Swaminathan, Rajesh | Salisbury, Adam | Landers, David | Raveendran, Ganesh | Ebrahimi, Ramin | Bach, Richard | Delehanty, Joseph | Shah, Raj | Brener, Sorin | Doroshow, Jonathan | Caixeta, Adriano | Precoma, Dalton | Dall'Orto, Frederico Toledo Campo | de Andrade, Pedro Beraldo | Dracoulakis, Marianna | Maia, Lília Nigro | Ritt, Luiz Eduardo Fontelles | Quadros, Alexandre | Filho, Dário Celestino Sobral | de Martino, Fernando | Huynh, Thao | Schnell, Greg | Senaratne, Manohara | Tandon, Vikas | Neary, John | Laflamme, David | Dery, Jean-Pierre | Bainey, Kevin | Haichin, Richard | Dehghani, Payam | Quraishi, Ata Ur Rehman | Potter, Brian | Carrier, François Martin | Goldfarb, Michael | Fordyce, Christopher | Sia, Ying Tung | Daneault, Benoit | Madan, Mina | Mcpherson, Terry | Ducas, John | Minhas, Kunal | Brass, Neil | Bagai, Akshay | Robinson, Simon | Džavík, Vladimír | Khan, Razi | Michaud, Nicolas | Steg, Gabriel | Ducrocq, Gregory | Puymirat, Etienne | Lemesle, Gilles | Ferrari, Emile | Lattuca, Benoit | Silvain, Johanne | Vanzetto, Gérald | Cetran, Laura | Lhermusier, Thibault | Cottin, Yves | Rosamel, Yann | Angoulvant, Denis | Dillinger, Jean Guillaume | Thuaire, Christophe | Popovic, Batric | Durand, Eric | Bouleti, Claire | Roubille, François | Delorme, Laurent | Crozier, Ian | Benatar, Jocelyne | Nandra, Samraj | Ternouth, Ian | Fisher, Nick | Brieger, David | Hillis, Graham

Edité par CCSD ; Elsevier -

International audience

Suggestions

Du même auteur

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Archive ouverte | Mcclanahan, Mark | CCSD

International audience. OBJECTIVE In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of lipoprotein(a) influences in...

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Archive ouverte | Schwartz, Gregory | CCSD

International audience. Background: Guidelines recommend nonstatin lipid-lowering agents in patients at very high risk for major adverse cardiovascular events (MACE) if low-density lipoprotein cholesterol (LDL-C) re...

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Archive ouverte | Ray, Kausik | CCSD

International audience. Background: An accurate estimation of the risk of life-threatening (LT) ventricular tachyarrhythmia (VTA) in patients with LMNA mutations is crucial to select candidates for implantable cardi...

Chargement des enrichissements...